<SEC-DOCUMENT>0001558370-22-010840.txt : 20220720
<SEC-HEADER>0001558370-22-010840.hdr.sgml : 20220720
<ACCEPTANCE-DATETIME>20220720080523
ACCESSION NUMBER:		0001558370-22-010840
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220720
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220720
DATE AS OF CHANGE:		20220720

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AYTU BIOPHARMA, INC
		CENTRAL INDEX KEY:			0001385818
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				470883144
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38247
		FILM NUMBER:		221092903

	BUSINESS ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(720) 437-6580

	MAIL ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC.
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rosewind CORP
		DATE OF NAME CHANGE:	20070110
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>aytu-20220720x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 9.6.8167.22744 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 7/20/2022 11:01:41 AM -->
      <!-- iXBRL Library version: 1.0.8167.22751 -->
      <!-- iXBRL Service Job ID: bae291cc-0b6d-41f4-ac3f-1427744361f6 -->

  <html xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:aytu="http://www.aytubio.com/20220720" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:EntityCentralIndexKey" id="Tc_5EW4yWPwjUCCPPBHhc95rw_1_1">0001385818</ix:nonNumeric><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:AmendmentFlag" id="Tc_Ap1IvYleGk2aegJf0Y_HJA_2_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="aytu-20220720.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001385818</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-20</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt 0pt 0pt 7.2pt;"><span style="font-size:1pt;font-weight:bold;margin-bottom:12pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_d0ddb65a_3065_4a95_9c54_c89a2f6cd6ae"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-size:14pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-size:14pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Washington, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:DocumentType" id="Narr_tgmAuZl8QESpx2o-5JZXqA"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-size:14pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Date of Report (Date of earliest event reported):</b><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_3fLPSCANNkOjQZQTlitdfQ"><b style="font-weight:bold;"> July 20, 2022</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:14pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:EntityRegistrantName" id="Narr_CtoBsTmAWkSjschKkj97IQ"><b style="font-weight:bold;">AYTU BIOPHARMA,&#160;INC.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">(Exact name of registrant as specified in its charter)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_bc388308_3872_4b3b_a834_1bde8e559995"></a><a id="Tc_CLW8tBt3CEaPcG_-AE8CRQ_2_0"></a><a id="Tc_SrMcbBun0UuYTy5kKUwFpQ_2_2"></a><a id="Tc_eJHsWSAGnEK1EkpxXhC4qA_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:39.81%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:middle;width:24.03%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td><td style="vertical-align:top;width:1.54%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:middle;width:32.78%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"></div></div></td></tr><tr><td style="vertical-align:middle;width:39.81%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_7kw88vZ5FUu8ZeGHcDGI_A_1_0"><b style="font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;width:24.03%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:EntityFileNumber" id="Tc_K06wbjVfQECtVpqY0NNUbw_1_2"><b style="font-weight:bold;">001-38247</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:1.54%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;width:32.78%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:EntityTaxIdentificationNumber" id="Tc_arEvfTYsH02fejole9OZXA_1_4"><b style="font-weight:bold;">47-0883144</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:middle;width:39.81%;border-top:1.0pt solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;">(State or other jurisdiction of incorporation)</p></td><td style="vertical-align:top;width:1.82%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:24.03%;border-top:1.0pt solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;">(Commission File Number)</p></td><td style="vertical-align:top;width:1.54%;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:middle;width:32.78%;border-top:1.0pt solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;">(IRS Employer Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:EntityAddressAddressLine1" id="Narr__97Oz9H9a06j0yURLxmxKA"><b style="font-weight:bold;">373 Inverness Parkway</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:EntityAddressAddressLine2" id="Narr_uhpT4PvxvUCBYBqQZJt-_w"><b style="font-weight:bold;">Suite&#160;206</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:EntityAddressCityOrTown" id="Narr_wkp2k0Y8NEuli-jveZNWXQ"><b style="font-weight:bold;">Englewood</b></ix:nonNumeric><b style="font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:EntityAddressStateOrProvince" id="Narr_Pcf2lWjR-EaW6tjPTBf69w"><b style="font-weight:bold;">CO</b></ix:nonNumeric><b style="font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:EntityAddressPostalZipCode" id="Narr_R_B6O189-UalmOBbU93BIw"><b style="font-weight:bold;">80112</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">(Address of principal executive offices, including Zip Code)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Registrant&#8217;s telephone number, including area code: (</b><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:CityAreaCode" id="Narr_bxgjOs7FOUakAM6PHhUXlA"><b style="font-weight:bold;">720</b></ix:nonNumeric><b style="font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:LocalPhoneNumber" id="Narr_L86yUhrTVkmwC7iqjdNmXA"><b style="font-weight:bold;">437-6580</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">N/A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">(Former name or former address, if changed since last report)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:18.25pt;"><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_Ff-fLuVOJEGfxLjxNv42DQ"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:18.25pt;"><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_taoavTepD0i5ugLnHFpttQ"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:18.25pt;"><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_HLjal7IjY0SvPokkP6sOXw"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="display:inline-block;width:18.25pt;"><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_cJuEpYsyHEOnUJnKxKskdw"><span style="font-family:'Segoe UI Symbol';font-size:10pt;font-style:normal;font-weight:normal;">&#9744;</span></ix:nonNumeric></span>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_810a9833_6b78_460d_b0c4_ce6f37bb1d34"></a><a id="Tc_YZZEhfMPuUWTyHu8hxTzVw_1_0"></a><a id="Tc_bYsEXvhpAE2O2zFsQDALJA_1_2"></a><a id="Tc_EKYkYCqxGUyKZJ3S2XLzJQ_1_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:40.38%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:1.54%;margin:0pt;padding:0.25pt 0pt 0.4pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:17.78%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:1.78%;margin:0pt;padding:0.25pt 0pt 0.4pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:38.5%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:40.38%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:top;width:1.54%;margin:0pt;padding:0.25pt 0pt 0.4pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:17.78%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Trading Symbol(s)</b></p></td><td style="vertical-align:top;width:1.78%;margin:0pt;padding:0.25pt 0pt 0.4pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;</b></p></td><td style="vertical-align:top;width:38.5%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-weight:bold;">Name of each exchange on which registered</b></p></td></tr><tr><td style="vertical-align:top;width:40.38%;background:#cceeff;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:Security12bTitle" id="Tc_jp4dxmp5K0CMLroD0tP4rg_2_0"><b style="font-weight:bold;">Common Stock, par value $0.0001 per share</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:1.54%;background:#cceeff;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:17.78%;background:#cceeff;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" name="dei:TradingSymbol" id="Tc_s5K3UQ9l00KchVpzPdDPEA_2_2"><b style="font-weight:bold;">AYTU</b></ix:nonNumeric></p></td><td style="vertical-align:top;width:1.78%;background:#cceeff;margin:0pt;padding:0.25pt 0pt 0.25pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:38.5%;background:#cceeff;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Tc_G4xvOt7y00mHYJMigGgi8Q_2_4"><b style="font-weight:bold;">The NASDAQ Stock Market LLC</b></ix:nonNumeric></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;text-indent:0pt;margin:0pt 0pt 10pt 7.2pt;">Emerging growth company <ix:nonNumeric contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_AaHFJkgcQU64rhJ0-GxHJw"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. &#9744;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_71582091_a394_45ed_8243_b6ab63e22011"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Item&#160;7.01 Regulation FD Dislosure</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">(d)</b> On July 20, 2022, Aytu BioPharma, Inc, (the &#8220;Company&#8221;) announced the initiation of the global Phase 3 PREVEnt (Prevention of Ruptures with Enzastaurin for Vascular Ehlers-Danlos Syndrome) clinical trial of enzastaurin (AR101) for the treatment of patients with COL3A1-positive Vascular Ehlers-Danlos Syndrome (VEDS). VEDS is a rare genetic disorder typically diagnosed in childhood and characterized by arterial aneurysm, dissection and rupture, bowel rupture and rupture of the gravid uterus. The Company has begun patient identification and study site contracting and has received regulatory clearance to initiate this registrational study in the United States and numerous countries in Europe.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_b92dce48_329d_493b_a168_937bdb521121"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;">Item 9.01. Financial Statements and Exhibits.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><a id="_91faf100_4325_4309_ad2e_21e520b46841"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:10.85%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:1.7%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:87.43%;margin:0pt;padding:0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:10.85%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">(d)&#160;Exhibits</b></p></td><td style="vertical-align:top;width:1.7%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;</p></td><td style="vertical-align:top;width:87.43%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Item</b></p></td></tr><tr><td style="vertical-align:top;width:10.85%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">99.1</p></td><td style="vertical-align:top;width:1.7%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:87.43%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="aytu-20220720xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press release dated July 20, 2022.</span></a></p></td></tr><tr><td style="vertical-align:top;width:10.85%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">104</p></td><td style="vertical-align:top;width:1.7%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:87.43%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_f6db38a4_5020_433f_9603_1ed5af3cb696"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">SIGNATURES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;width:3.1%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:top;white-space:nowrap;width:43.11%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:top;width:46.21%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">AYTU BIOPHARMA,&#160;INC.</p></td></tr><tr><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:top;width:46.21%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td colspan="2" style="vertical-align:top;width:46.21%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: July 20, 2022</p></td><td style="vertical-align:top;width:3.1%;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By: </p></td><td style="vertical-align:top;white-space:nowrap;width:43.11%;border-bottom:1px solid #000000;margin:0pt;padding:0.25pt 0.25pt 0.4pt 0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">/s/&#160;Mark Oki</p></td></tr><tr><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:3.1%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:43.11%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Mark Oki</p></td></tr><tr><td style="vertical-align:top;width:53.78%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:3.1%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:top;width:43.11%;margin:0pt;padding:0.25pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Financial Officer</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6.09pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>aytu-20220720xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.14.0.96--><!--Created on: 7/20/2022 11:01:54 AM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 99.1</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="color:#ff0000;font-weight:bold;"><img src="aytu-20220720xex99d1001.jpg" alt="Text  Description automatically generated with low confidence" style="display:inline-block;height:56.35pt;left:0%;padding-bottom:0.65pt;position:relative;top:0pt;width:138.7pt;"></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:18pt;font-weight:bold;">Aytu BioPharma Announces Initiation of the AR101 PREVEnt Trial for the Treatment of Vascular Ehlers-Danlos Syndrome</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">ENGLEWOOD, CO / July 20, 2022</b><font style="font-size:12pt;"> / Aytu BioPharma, Inc. (Nasdaq: AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the initiation of the global Phase 3 PREVEnt (</font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">P</u><font style="font-size:12pt;">revention of </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">R</u><font style="font-size:12pt;">uptures with </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">E</u><font style="font-size:12pt;">nzastaurin for </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">V</u><font style="font-size:12pt;">ascular </font><u style="font-size:12pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">E</u><font style="font-size:12pt;">hlers-Danlos Syndrome) clinical trial of enzastaurin (AR101) for the treatment of patients with COL3A1-positive Vascular Ehlers-Danlos Syndrome (VEDS). VEDS is a rare genetic disorder typically diagnosed in childhood and characterized by arterial aneurysm, dissection and rupture, bowel rupture and rupture of the gravid uterus. The company has begun patient identification and study site contracting and has received regulatory clearance to initiate this registrational study in the United States and numerous countries in Europe.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;white-space:pre-wrap;">&#8220;We are excited about the progression of this global clinical trial evaluating a novel pathway for the treatment of VEDS, a devastating rare disease with massive unmet need,&#8221; said Josh Disbrow, Chief Executive Officer of Aytu BioPharma.  &#8220;The PREVEnt Trial is global in nature with an anticipated 30+ sites across the US and Europe.  We have received an FDA Safe to Proceed Letter, and in Europe have garnered Regulatory Authority and Ethics Commission approvals to begin clinical work in multiple countries. We anticipate additional country-specific approvals in the coming months.&#8221;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Topher Brooke, Executive Vice President of Rare Disease Development of Aytu BioPharma, commented, &#8220;We are so grateful to all the clinical trial sites for their efforts in aiding our study start up with the aim of dosing a first patient by early 2023. In coordination with trial sites and patient advocacy organizations in the US and Europe, we plan to make it as easy as possible to participate in the PREVEnt Trial, including allowing patients to continue any VEDS-related therapies they are currently taking for the duration of the study.&#8221;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;white-space:pre-wrap;">The PREVEnt Trial is a prospective, Phase 3, global, randomized, double-blind, placebo-controlled efficacy trial designed to evaluate enzastaurin in patients with genetically confirmed COL3A1-positive VEDS.  The primary measure of the trial is to determine whether enzastaurin reduces the occurrence of VEDS-related arterial events (ruptures, dissections, pseudoaneurysms, carotid-cavernous fistula, aneurysm) requiring medical intervention compared to placebo.  The company expects to enroll approximately 260 COL3A1-confirmed VEDS patients in the PREVEnt Trial. Individuals seeking more information on the enzastaurin pivotal clinical trial are invited to visit </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;white-space:pre-wrap;">www.preventvedstrial.com and https://clinicaltrials.gov/ct2/show/NCT05463679?term=Aytu+BioPharma&amp;draw=2&amp;rank=1.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">About Aytu BioPharma, Inc.</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Aytu BioPharma is a pharmaceutical company with a portfolio of commercial prescription therapeutics and consumer health products, and a growing therapeutics pipeline focused on treating rare, pediatric-onset disorders. The company&#39;s prescription products include Adzenys XR-ODT&#174; (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) and Cotempla XR-ODT&#174; (methylphenidate) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of attention deficit hyperactivity disorder (ADHD), as well as Karbinal&#174; ER (carbinoxamine maleate), an extended-release antihistamine suspension indicated to treat numerous allergic conditions, and Poly-Vi-Flor&#174; and Tri-Vi-Flor&#174;, two complementary fluoride-based prescription vitamin product lines available in various formulations for infants and children with fluoride deficiency. Aytu is also building a therapeutic pipeline, which includes AR101 (enzastaurin), a PKC&#946; inhibitor in development for the treatment of Vascular Ehlers-Danlos Syndrome (VEDS). VEDS is a rare genetic disease typically diagnosed in childhood resulting in high morbidity and a significantly shortened lifespan, and for which there are no currently approved treatments. AR101 has received Orphan Drug designation and Fast Track designation from the U.S. Food and Drug Administration and has received Orphan Drug designation from the European Commission. Aytu is also researching and advancing the development of the Healight ultraviolet light A (UVA) endotracheal catheter, a patented, investigational medical device with potential application in the treatment of severe, difficult-to-treat respiratory infections. To learn more, please visit aytubio.com.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Forward-Looking Statements</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;white-space:pre-wrap;">This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. All statements other than statements of historical facts contained in this press release, are forward-looking statements. Forward-looking statements are generally written in the future tense and/or are preceded by words such as &#39;&#39;may,&#39;&#39; &#39;&#39;will,&#39;&#39; &#39;&#39;should,&#39;&#39; &#39;&#39;forecast,&#39;&#39; &#39;&#39;could,&#39;&#39; &#39;&#39;expect,&#39;&#39; &#39;&#39;suggest,&#39;&#39; &#39;&#39;believe,&#39;&#39; &#39;&#39;estimate,&#39;&#39; &#39;&#39;continue,&#39;&#39; &#39;&#39;anticipate,&#39;&#39; &#39;&#39;intend,&#39;&#39; &#39;&#39;plan,&#39;&#39; or similar words, or the negatives of such terms or other variations on such terms or comparable terminology. All statements other than statements of historical facts contained in this press release, are forward-looking statements, including but not limited to any statements regarding the financial results and statements presented in this press release and during the business update call following its release. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include, among others: the anticipated start dates, durations and completion dates and the potential future results of ongoing and future AR101 clinical trials, the effectiveness of AR101 in treating VEDS and the anticipated future regulatory submissions and events related to AR101. We also refer you to (i) the risks described in &#39;&#39;Risk Factors&#39;&#39; in Aytu&#39;s Annual Report on Form 10-K, in Quarterly Reports filed on Form 10-Q,  and in the other reports and documents it files with the Securities and Exchange Commission.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:12pt;font-weight:bold;">Contact for Investors:</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:12pt;">Mark Oki, Chief Financial Officer</font><font style="font-size:12pt;"><br></font><font style="font-size:12pt;">Aytu BioPharma, Inc</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><font style="font-size:12pt;">moki@aytubio.com</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 5pt 0pt;"><b style="font-size:12pt;font-weight:bold;">SOURCE</b><font style="font-size:12pt;">:&#160;Aytu BioPharma, Inc</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>aytu-20220720xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 aytu-20220720xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !Q 18# 2(  A$! Q$!_\0
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MEG_M#2[A,C"[LX!'H>*_6?\ 9#^.]O\ '[X-Z5K9D4ZK;H+:_B'595'7\>M
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MC(W$9!KU:_\ VEOAK8^*],\.?\);IUQK&HR>5!!;3"3)]R.!0(^<?^"L7_)
M-,X_YBJ?^@UX_P#\$@W7^V/&:Y&[RXSBOJK]O_X8WGQ._9TUN#3HOM%[I^+V
M.,#DA>N/PK\Q_P!B#]HRW_9R^+8O-863^P[]/LM[M&3%S]['L:!K8_<JBN(\
M-?&WP'XNTN'4-+\6Z1<6\JAP3>1JP'N"<BN!^,G[9OPP^#FC37-YXCM-4OPI
M\FPTZ59GD;L/E.!02?''_!7TC^VO!8W+GRI/ESSUKU?_ ().?\D3U;_K_/\
M*OSR_:6^+WBWX_\ BMO'.MVDUKHUP[0:<A_U<:#^%3W/K7Z&_P#!)W_DB>K?
M]?Y_E05T/N6BBB@D**** "JFJZ9;:UIMU87<2S6MS&T4D;#(92,$5;HHVU$T
MI*S/RS^.'PON?A-\0+[1Y%)LV8S6<O9XB>/Q'0UP*1F:1(U&6=@H'UK]&?VK
MO@['\2_ 4VH6D.[7-)1IK<H,M(G5H_Q_G7P'X&T_[?XQTRVD4C]\"RD=,5]3
M_:$88&IBI?\ +N+;^2O^)^%9ID\L)F4<-#X:C7+Z-VM\CZ!T.P71]&L;./($
M$2KGOG'/ZUJIJ=W&,+=3*/\ 9D(JNQRQ/O25_$\JU2I.563]Z3;?J]6?T#"$
M:<5".R5EZ(CO=4OG!!O+@_65O\:Y;4B\SYD=I#ZL<UT=VF0:P+],Y]!7J8:I
M)VNSCKQNFCQ_Q#:"QUJY0#Y6.\?C46D:9<ZWJ=K86D32W-S((XT49R2<5M^/
M(-E[;2@<,"I-?0G[%_PB.I:E)XSU&'_1[8F.R5U^\_=Q]*^TP&&EC:T:4>N_
MH?TK@,_CA^&:.95G>2C;UDO=_%JY]*?!CX;V_P +_ =AI$:J;K;YES(!@O(>
MO^'X5V6I+<OI]RMFR+=F-A$TGW0V.,^V:LT5^Q4J<:,%3@K)'\YXC$5,56E7
MJN\I.[^9^:GC#_@EOXU^(?CN_P#$FO\ CNRN+C4+HSW!\EB<$_='T'%?H1\.
M_ ^G_#;P3H_AK2XEBLM.MU@0*,9P.3^)R:Z.BM3"]PHHHH$%?._[8_[)]M^U
M!X/LK2"ZBTS7+&7?;WLB;@%/WE/M7T110!\7?L@?L6>./V8/&UQ?'Q;9ZGH5
M]'Y=W8K&PW$?=9>V17)_\%6OB_H&F> =/\"F""^UZ^D%R"PRUM&O\7L3TK[7
M^)'CW2_AEX*U;Q+K$ZV]CI\#3.S'J0. /<FOQ!U"[\2?MF?M)AMKR7&LWH1%
M&2L%N#^@"T%+74^I?^"5_P"S@=1U.Z^)^LVX-M;$P:8KC[S_ ,3_ (>OK7Z?
MURWPP^'VF_"WP)H_AC28A%9Z? L0P.68#EC[DUCZS\</#6AZQ=:;+]NFN+5@
MLQMK1Y$C/7D@4">IZ#7S)^V!^Q1HG[3=A#J%O<C1_%=HFR"]VY21?[CCT]Z]
MS@^)/A^Z_L?R+X3#56*VI12=Q'4'T/UK+U_XT^&_#^IRV+O=WDL)Q.]E;/,D
M/^\RC H$?DSJO_!,;XV:7J4D-M86%[&K86Y@NL*1Z\C->P? '_@EKXQTWQ3I
M7B#QEK]MHZV5PMPMMIY,DK%3D L<8_6OT1UGXK^'-%T"RUB2Z>YLKQPD!MHS
M(SL>VT<YJMI7QH\+ZM:WLR74UN]G'YLUO<P/'*$_O!2,D?2@=V=D+.-K$6LP
M^T1^7Y;"09WC&#FO@#]IK_@EU;>-]=O?$?PYU"WTBZN6,LNE78(A9SR2K#[O
MTQ7W;JGB[3-'\/)K=U.8]/94<2;2>&Z<?C4?B3QOHWA'18]5U6\6ULI"H61N
MY;IQ0*]C\=1_P36^.MG<-'#I5J 3@R17>%(KVCX+_P#!)G5[C4;>_P#B1KEO
M;VBL'?3M-)=Y!Z,YQC]:_2/Q)XSTKPKX?_MJ_F9;#"D/&A<MNZ8 ZYK"\/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
5110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>aytu-20220720.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8167.22744 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/20/2022 11:01:46 AM-->
<!--Modified on: 7/20/2022 11:01:46 AM-->
<xsd:schema targetNamespace="http://www.aytubio.com/20220720" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:srt-roles="http://fasb.org/srt-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:aytu="http://www.aytubio.com/20220720" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dei="http://xbrl.sec.gov/dei/2021q4">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.aytubio.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="aytu-20220720_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="aytu-20220720_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>aytu-20220720_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8167.22744 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/20/2022 11:01:46 AM-->
<!--Modified on: 7/20/2022 11:01:46 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Adress Line Two</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>aytu-20220720_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--XBRL document created with Toppan Merrill Bridge  9.6.8167.22744 -->
<!--Based on XBRL 2.1-->
<!--Created on: 7/20/2022 11:01:46 AM-->
<!--Modified on: 7/20/2022 11:01:46 AM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="aytu-20220720.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.aytubio.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.aytubio.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType_637939117065207653" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_637939117065207653" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_637939117065207653" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_637939117065207653" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_637939117065207653" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_637939117065207653" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_637939117065217654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_637939117065217654" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_637939117065217654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_637939117065217654" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_637939117065217654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_637939117065217654" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_637939117065217654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_637939117065217654" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_637939117065217654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine2_637939117065217654" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_637939117065217654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_637939117065217654" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_637939117065217654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_637939117065217654" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_637939117065217654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_637939117065217654" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_637939117065217654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_637939117065217654" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_637939117065217654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_637939117065217654" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_637939117065217654" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_637939117065217654" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_637939117065230400" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_637939117065230400" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_637939117065230400" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_637939117065230400" order="16" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_637939117065230400" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_637939117065230400" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_637939117065230400" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_637939117065230400" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_637939117065230400" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_637939117065230400" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_637939117065230400" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_637939117065230400" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_637939117065237661" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_637939117065237661" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_637939117065237661" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_637939117065237661" order="22" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_637939117065237661" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_637939117065237661" order="23" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139894572768368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 20, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 20,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AYTU BIOPHARMA,&#160;INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-0883144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">373 Inverness Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Adress Line Two</a></td>
<td class="text">Suite&#160;206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Englewood<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">437-6580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AYTU<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001385818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>aytu-20220720x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="aytu-20220720.xsd" xlink:type="simple"/>
    <context id="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001385818</identifier>
        </entity>
        <period>
            <startDate>2022-07-20</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Tc_5EW4yWPwjUCCPPBHhc95rw_1_1">0001385818</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Tc_Ap1IvYleGk2aegJf0Y_HJA_2_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_tgmAuZl8QESpx2o-5JZXqA">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_3fLPSCANNkOjQZQTlitdfQ">2022-07-20</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_CtoBsTmAWkSjschKkj97IQ">AYTU BIOPHARMA,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Tc_7kw88vZ5FUu8ZeGHcDGI_A_1_0">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Tc_K06wbjVfQECtVpqY0NNUbw_1_2">001-38247</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Tc_arEvfTYsH02fejole9OZXA_1_4">47-0883144</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr__97Oz9H9a06j0yURLxmxKA">373 Inverness Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_uhpT4PvxvUCBYBqQZJt-_w">Suite&#160;206</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_wkp2k0Y8NEuli-jveZNWXQ">Englewood</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_Pcf2lWjR-EaW6tjPTBf69w">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_R_B6O189-UalmOBbU93BIw">80112</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_bxgjOs7FOUakAM6PHhUXlA">720</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_L86yUhrTVkmwC7iqjdNmXA">437-6580</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_Ff-fLuVOJEGfxLjxNv42DQ">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_taoavTepD0i5ugLnHFpttQ">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_HLjal7IjY0SvPokkP6sOXw">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_cJuEpYsyHEOnUJnKxKskdw">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Tc_jp4dxmp5K0CMLroD0tP4rg_2_0">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Tc_s5K3UQ9l00KchVpzPdDPEA_2_2">AYTU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Tc_G4xvOt7y00mHYJMigGgi8Q_2_4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA"
      id="Narr_AaHFJkgcQU64rhJ0-GxHJw">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MP %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ JD#T5)>*NQS     $P(
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MB^$_7G\!4$L! A0#%     @ JD#T5 =!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "J0/14IEYF&^X
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M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( *I ]%27BKL<P    !,"   +
M      "  8P/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *I ]%0<.&7J/P$
M #P"   /              "  740  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " "J0/14)!Z;HJT   #X 0  &@              @ 'A$0  >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "J0/1499!YDAD!  #/
M P  $P              @ '&$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    "0 ) #X"   0%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="aytu-20220720x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.aytubio.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="aytu-20220720x8k.htm">aytu-20220720x8k.htm</File>
    <File>aytu-20220720.xsd</File>
    <File>aytu-20220720_lab.xml</File>
    <File>aytu-20220720_pre.xml</File>
    <File>aytu-20220720xex99d1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "aytu-20220720x8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "aytu-20220720x8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "aytu-20220720_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aytu-20220720_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "aytu-20220720.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "aytu",
   "nsuri": "http://www.aytubio.com/20220720",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aytu-20220720x8k.htm",
      "contextRef": "Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00090 - Document - Document and Entity Information",
     "role": "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aytu-20220720x8k.htm",
      "contextRef": "Duration_7_20_2022_To_7_20_2022_OYbbIAvNoUuP-ID31v_PBA",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Adress Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.aytubio.com/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001558370-22-010840-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-22-010840-xbrl.zip
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M+Z/]H^E, <[!1+[<QRQ:47!<_0902P,$%     @ JD#T5%@.^N./!0  [CX
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M]65E$@-6$SNUS0#_OG824P@)A*K=3*318.*3ZW//,8YODOL/NR@$KXAQ3,G
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MA$/T>1,M$"MP( ]IAOB56&>ZM^K2_06ML*)/Q&<8%<W^(MAI)J[,I/UF]:_
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M9)K,9$R:PJ"*4@A!,& TAH-.,C*TJ3*>6B.5.KM!'4O.QR2/.R-VBN6W""5
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MTM#1<  >D9B2N@#<ZS-"UX7I3F@@F=1,%E\.P762.T)9EAG*7].JET(53TT
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M   1              "  0    !A>71U+3(P,C(P-S(P+GAS9%!+ 0(4 Q0
M   ( *I ]%18#OKCCP4  .X^   5              "  9@#  !A>71U+3(P
M,C(P-S(P7VQA8BYX;6Q02P$"% ,4    " "J0/14A9([)8T$  #I)P  %0
M            @ %:"0  87ET=2TR,#(R,#<R,%]P<F4N>&UL4$L! A0#%
M  @ JD#T5-L_R+UR%   08H  !0              ( !&@X  &%Y='4M,C R
M,C W,C!X.&LN:'1M4$L! A0#%     @ JD#T5*O>X@RQ#@  @S$  !@
M         ( !OB(  &%Y='4M,C R,C W,C!X97@Y.60Q+FAT;5!+!08
..!0 % $T!  "E,0     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
